# MiNK Therapeutics, Inc.: Form 8-K, filed Mar 19, 2026

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: 8-K
- Filed: 2026-03-19
- Accepted by EDGAR: Mar 19, 2026, 17:21 ET
- Period: 2026-03-13
- Accession: 0001193125-26-116219
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000119312526116219/inkt-20260313.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000119312526116219/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000119312526116219/inkt-20260313.htm

Filed Mar 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-116219. Last ingested by Listed: Nov 12, 2026, 21:09 ET. No prices; not investment advice.
